HST Global, Inc. is a biotechnology and wellness company. The company discovers and develops breakthroughs in supporting and treating metabolic disorders associated with cancer and other life threatening illnesses. It develops and acquires a network of wellness centers, that are focused on the homeopathic and alternative treatment of stage cancer. HST Global was founded on April 11, 1984 and is headquartered in Hampton, VA.
Company profile
Ticker
HSTC
Exchange
Website
CEO
Ronald R. Howell
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ABSS CORP, NT HOLDING CORP., UNICO INC
SEC CIK
Corporate docs
IRS number
731215433
HSTC stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
5 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
11 Aug 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
31 Jan 23
10-Q
2022 Q3
Quarterly report
4 Nov 22
10-Q
2022 Q2
Quarterly report
26 Jul 22
10-Q
2022 Q1
Quarterly report
29 Apr 22
10-K
2021 FY
Annual report
4 Mar 22
Latest ownership filings
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |